Posted by Michael Wonder on 01 Apr 2024
PHARMAC publishes agenda for May 2024 PTAC meeting
28 March 2024 - Another slim agenda; one cancer medicine.
The PTAC will consider funding applications for the following medicines at its next meeting on 16-17 May 2024:
- Deflazacort - Duchenne muscular dystrophy
- Selexipag - Pulmonary arterial hypertension
- Macitentan - Pulmonary arterial hypertension
- Pembrolizumab - Cervical cancer
- Pembrolizumab - Renal cell carcinoma
Read PTAC agenda
Posted by:
Michael Wonder